A1 Yola is a modern hybrid-indica strain bred from Triple OG. This variety is designed for growers of moderate experience level and thrives in both indoor and outdoor environments. Cultivators can expect a high yield from this plant, which maintains a flowering cycle of 60 days. There are currently no recorded offspring from this specific genetic lineage.

The aromatic and sensory profile of A1 Yola is driven by a complex terpene profile beginning with limonene as the dominant compound, followed by myrcene and caryophyllene. The secondary and tertiary tiers include linalool, beta-pinene, bisabolol, pinene, humulene, and terpinolene, which collectively shape the strain's olfactory experience. This chemical composition is paired with a THC-dominant profile testing at approximately 24.8 percent, with a negligible CBD content of zero percent.

Consumers report that A1 Yola induces a balanced state of relaxation and mental focus. These effects make the strain particularly suitable for managing physical pain and reducing stress, and some users incorporate it into their routine to facilitate sleep. Due to its balanced hybrid-indica classification, the strain serves as a targeted option for those seeking sustained physiological relief without total cognitive impairment.